246 filings
Page 4 of 13
424B5
a3m896dogsvjyou0qs
31 Jan 23
Prospectus supplement for primary offering
8:51am
8-K
ma097nk 05
31 Jan 23
Nemaura Medical Announces Pricing of Approximately $8.4 Million Registered Direct Offering and Concurrent Private Placement
8:36am
8-K
tp56y0o3bzt6ymx4d28i
26 Jan 23
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
8:01am
8-K
2l5r x98p6cmg6lexqn8
25 Jan 23
Regulation FD Disclosure
6:07am
8-K
9ccsgll coor
24 Jan 23
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
4:28pm
8-K
n1z l5z4j1
14 Nov 22
Nemaura Medical Reports Fiscal Second Quarter 2023 Results and Provides Business Update
5:21pm
8-K
meck4ae3inbcw74
26 Oct 22
Entry into a Material Definitive Agreement
4:19pm
8-K
5r3j6x7 0wc
12 Oct 22
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
12:51pm
8-K
wz592lbj9e0kvxz
8 Jul 22
Departure of Directors or Certain Officers
4:05pm
8-K
h2x3nq18oqwy1r
1 Jul 22
Results of Operations and Financial Condition
11:59am
424B5
x4xrkch2 klrvb
1 Apr 22
Prospectus supplement for primary offering
4:29pm
8-K
4zu lcm7wz
1 Apr 22
Entry into a Material Definitive Agreement
4:12pm
EFFECT
xuljp3sud 8ernd4snt
29 Mar 22
Notice of effectiveness
12:15am
CORRESP
ri2r f7qe24gs260
24 Mar 22
Correspondence with SEC
12:00am
UPLOAD
9mv8 s3kq6ftdvbn
23 Mar 22
Letter from SEC
12:00am